FDA.reportPublic FDA data

Actoplus Met 15/500 MG Oral Tablet

RxCUI
861785
RxNorm name
Actoplus Met 15/500 MG Oral Tablet
Display name
Actoplus Met 15/500 MG Oral Tablet
Full name
Actoplus Met 15/500 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f5c534e8-656c-406d-b3dc-b562576ba4ebactoplus met 15 MG / 500 MG Oral Tablet [PSN] · metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met] [SBD] · Actoplus Met 15/500 (metformin hydrochloride 500 MG / pioglitazone (as pioglitazone hydrochloride) 15 MG) Oral Tablet [SY] · Actoplus Met 15/500 MG Oral Tablet [SY]42ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets20100224